Top 5 Oxygen Concentrators for COPD Home Use in India (2026)

A COPD patient on long-term oxygen therapy (LTOT) is going to run the same concentrator for 12 to 24 hours a day, every day, for years. The buyer decision is fundamentally different from a short-term post-COVID rental or a portable-for-travel pick. What matters: low published noise that doesn’t wake the patient at night, power draw that keeps a 24/7 prescription affordable on Indian domestic tariffs, a dealer or manufacturer who actually answers the phone at month 14 when the compressor starts misbehaving, and a warranty long enough to bridge the wear-out window of the sieve beds and compressor. This ranking covers the five units HHZ considers the strongest LTOT choices for an Indian COPD household in 2026. The default pick for an urban Indian buyer with a stable 1–4 LPM prescription is the Oxymed Mini 5L on the strength of its dealer-network reach; the Home Medix HM-KV is the strongest pick for buyers who prioritise warranty length and lowest power draw over dealer density.

For the buyer checklist version of this decision, see best oxygen concentrator for COPD patient at home in India. For overnight prescriptions, also see oxygen concentrator for night use.

How we ranked

Long-term COPD home use weighs differently from a generic 5 LPM ranking. For chronic-condition buyers we re-weight the rubric toward published warranty terms, dealer and service-centre footprint, power draw at typical operating flow, and bedside noise. Continuous-flow capability (not pulse-dose) is required — pulse-dose units are inappropriate for stable resting hypoxaemia. Flow-rate floor matters too: some COPD prescriptions run as low as 0.5–1 LPM overnight, so units that cannot titrate below 1 LPM are excluded from the top tier. All performance numbers cited below come from manufacturer brochures and e-commerce product listings; HHZ has not run bench tests on these specific units. The full rubric is at our methodology page.

The top 5

1. Oxymed Mini 5 LPM — 8.3

Price snapshot — indicative retail ₹35,400 (listed MRP ₹59,900), 13.9 kg, 1–5 L/min continuous flow, 90–96% purity, 45 dB published sound, 390 W draw.

Pros

• Broadest dealer and service-centre footprint of any concentrator brand in the Indian indigenous tier — the brand claims 40+ service centres and the public dealer-listing density is the highest in the category. For a chronic-use patient who will need service calls over a multi-year horizon, this is the single most important attribute.
• Active CDSCO manufacturing licence MFG/MD/2024/000436, most recently re-issued 3 February 2026 — signals ongoing manufacturer engagement with the platform, which matters for spare-parts continuity over a long ownership horizon.
• 45 dB published sound is below the bedside-disruption threshold for most patients; continuous-flow up to 5 LPM covers the full COPD prescription range; 13.9 kg chassis allows single-caregiver bedroom-to-bedroom transitions.
• The Indian manufacturing operation (with Chinese subassembly sourcing — see transparency note below) puts service escalation in-country; warranty claims don’t depend on an overseas importer relationship.

Cons

• The Indian manufacturing operation operates a kit-assembly pattern: the same model codes (AR-5-N, MAOXY 05) appear on both Medequip’s CDSCO manufacturing licence and their import licences for units sourced from Shenyang Aerti Tech Co., China. The Indian operation is final-stage assembly, not full indigenous build from raw components. Buyers prioritising indigenous supply chain should weigh this against the service-network advantage.
• 1 LPM flow floor; patients with sub-1 LPM overnight prescriptions need to titrate above 1 LPM or look at AirSep Visionaire 5 (0.5 LPM floor).
• 390 W power draw is mid-pack — annual electricity cost on 24/7 use sits between the most efficient (AirSep Visionaire 5 at 290 W) and the least efficient indigenous peers (550 VA+).

Best for — the stable 1–4 LPM COPD patient in metro or tier-2 India where rapid service-call response over the 5–8 year prescription horizon is the primary concern.

Full review at /oxygen-concentrators/oxymed-mini-5-lpm/.

2. Home Medix HM-KV 5 LPM — 8.2

Price snapshot — indicative retail ₹37,800 (listed MRP ₹54,000), 13 kg, 0.5–5 L/min continuous flow, 93% ± 3% purity, ≤40 dB published sound, 320 VA draw, 3-year or 10,000-hour warranty.

Pros

• 3-year / 10,000-hour warranty is the longest in the Indian indigenous 5 LPM segment. Over the typical 5–8 year COPD home-oxygen prescription, the warranty bridges the wear-out window of the first compressor or sieve-bed replacement cycle — meaningful versus 1-year or 2-year peer warranties.
• ≤40 dB published sound is the quietest in the Indian indigenous cohort and ties with the imported premium tier — material for COPD patients who run the unit overnight at the bedside.
• 320 VA power draw is the lowest in the Indian indigenous 5 LPM cohort. On 24/7 use at typical urban Indian commercial tariffs, this translates to roughly ₹3,000–₹5,000 less annual electricity cost versus indigenous peers running 500+ VA.
• 0.5–5 LPM flow range covers the full COPD prescription band including sub-1 LPM overnight titration — same flow floor as AirSep Visionaire 5, which is the only imported peer offering that low.
• Clean Bucket A CDSCO manufacturing licence (MFG/MD/2025/000522, issued 6 August 2025) with no parallel import licence on record — service escalation goes directly to the Bengaluru manufacturing facility rather than through an importer layer.
• Integrated nebulisation and One-Touch SOS Alert (audible local-siren button) are useful for COPD patients who may have intermittent exacerbations requiring caregiver attention.

Cons

• Dealer footprint (DLI tier 3) is more modest than Oxymed and the imported tier — buyers in tier-3 cities and smaller towns should confirm local service availability before commitment, particularly if they’re not within reasonable shipping distance of Bengaluru.
• US FDA / CE certifications are not on the published spec sheet (CDSCO + ISO 9001 + ISO 13485 only) — fine for the Indian market but not for buyers wanting overseas-validated regulatory layers.

Best for — the COPD patient prioritising lowest 24/7 electricity cost, lowest bedside noise, and longest warranty in the indigenous category, with realistic access to either a regional dealer or direct manufacturer service via Bengaluru.

Full review at /oxygen-concentrators/home-medix-5-lpm/.

3. AirSep Visionaire 5 — 8.0

Price snapshot — indicative retail ₹54,999 (listed MRP ₹80,640), 13.6 kg, 0.5–5 L/min continuous, 90–96% purity, 45 dB sound, 290 W draw, 10,000 ft altitude tolerance.

Pros

• 290 W published power draw is the lowest in the entire 5 LPM class. On a 24/7 COPD prescription at metro commercial tariffs, this saves roughly ₹4,000–₹6,000 per year versus the 390 W Oxymed Mini and roughly ₹7,000–₹9,000 versus 550 VA indigenous peers.
• 0.5 LPM flow floor matches the HM-KV — only two units in this top 5 can titrate that low, useful for sub-1 LPM overnight prescriptions.
• Complete alarm suite (loss of power, system malfunction, no-flow, Oxygen Purity Indicator) — the fullest unattended-operation safety stack of any unit in this top 5.
• 10,000 ft altitude tolerance opens hill-station deployments (Nainital, Manali, parts of Uttarakhand and Himachal) that other top-tier 5 LPM units can’t rate for.
• Imported under CDSCO IMP/MD/2025/000687 to Ujjwal Medical Devices India Pvt Ltd — current and active import licence.

Cons

• Indicative retail ₹54,999 is 45–55% above the indigenous top two — the energy savings pay back over 4–7 years on 24/7 use, but the upfront capital outlay is real.
• CAIRE/AirSep India service footprint is thinner than Philips Respironics, Oxymed, or BPL in the post-COVID Indian channel structure — service-call lead times in tier-2 and tier-3 cities can stretch to 14–21 days.
• Foreign-brand import (Bucket D); service continuity depends on Ujjwal Medical Devices maintaining the importer relationship and renewing the CDSCO import licence on schedule.

Best for — buyers in tier-1 cities with reasonable AirSep dealer presence, or at hill-station altitudes between 7,500 and 10,000 ft where the EverFlo’s 7,500 ft ceiling is disqualifying, or where the lowest published power draw in the class genuinely matters for 24/7 cost economics over a 5+ year horizon.

Full review at /oxygen-concentrators/airsep-visionaire-5/.

4. Nidek Nuvo Lite 5 LPM — 7.8

Price snapshot — indicative retail ₹57,599 (listed MRP ₹66,240), 13.6 kg, 0.5–5 L/min continuous, 90–96% purity, 40 dB sound, 290 W draw.

Pros

• 40 dB published sound ties the HM-KV as the quietest in the 5 LPM class — material for COPD patients who run the unit overnight.
• 290 W power draw matches the AirSep Visionaire as the lowest in the 5 LPM class.
• Premium build quality and Nidek’s long-standing reputation in respiratory equipment — patients and caregivers familiar with the brand have confidence in the platform.
• Imported under CDSCO IMP/MD/2024/000202 to Nidek Medical India Pvt Ltd from the US manufacturing site (Nidek Medical Products Inc.), with adjacent licence IMP/MD/2025/000484 covering same-class units sourced from Shenyang Aerti — buyers should confirm with the dealer which manufacturing origin applies to the specific unit being purchased.

Cons

• Indicative retail ₹57,599 is the highest in this top 5 — buyers pay a meaningful premium versus the indigenous tier for matched noise and power specs.
• Foreign-brand import (Bucket D); service continuity depends on Nidek Medical India’s licence renewal cycle. The original Nuvo Lite import licence dates to March 2024.
• The Shenyang Aerti adjacent licence introduces ambiguity about manufacturing origin on units sold through some Indian channels — same-spec Aerti-built units may carry different long-term service profile than US-built Nidek units.

Best for — buyers in metro India who specifically value the Nidek brand heritage and premium build feel, and who can verify their dealer is sourcing the US-built variant rather than the Aerti adjacent line.

Full review at /oxygen-concentrators/nidek-nuvo-lite-5-lpm/.

5. DeVilbiss 5 LPM (Compact 525) — 7.5

Price snapshot — indicative retail ₹45,984 (listed MRP ₹86,400), 16.3 kg, 1–5 L/min continuous, 90–96% purity, 48 dB sound, 310 W draw.

Pros

• 310 W power draw is among the most efficient in the 5 LPM class — second only to AirSep Visionaire 5 and Nidek Nuvo Lite at 290 W.
• Drive DeVilbiss has an established Indian service footprint with 22 authorised service centres claimed nationally — solid coverage for chronic-use service needs.
• Long-standing brand reputation in oxygen therapy; technicians across most Indian medical-equipment service networks are familiar with the platform.
• Imported under CDSCO IMP/MD/2025/000547 to Sanrai Med India, which also handles the Inogen and DeVilbiss portable lines — a meaningful single-importer service relationship.

Cons

• 48 dB sound is the highest in this top 5 — at the edge of bedside acceptability for light-sleeping COPD patients on overnight prescription.
• 16.3 kg chassis is the heaviest in this top 5 — less suited to bedroom-to-bedroom transitions, more of a fixed-installation unit.
• Indicative retail ₹45,984 places it above the indigenous top two on price; foreign-brand import (Bucket D) means service continuity depends on Sanrai Med maintaining the partnership.

Best for — buyers who want a known brand with broad Indian service-centre coverage, willing to accept the highest noise in this top 5 in exchange for the brand and service backbone. Strongest fit for fixed-installation use in a dedicated oxygen room rather than rotation between bedrooms.

Full review at /oxygen-concentrators/devilbiss-5-lpm/.

A note on Philips EverFlo and the COPD market

The Philips EverFlo has historically been the default Indian COPD home-oxygen pick — widest service footprint, established prescribing channel awareness, and a known platform across most Indian respiratory clinics. Philips Respironics has now officially discontinued the EverFlo product line globally, and Philips India’s import licence (IMP/MD/2022/000651) has not been refreshed since November 2022. Units still on Indian dealer shelves are clearance inventory. For a chronic-condition buyer entering a 5+ year prescription horizon, buying into a discontinued line means accepting structural risk on long-term spare-parts and service continuity. We’ve excluded EverFlo from the top 5 on that basis. The full discontinuation context is in our CDSCO licence-trail article.

Adjacent decisions

• Top 5 5 LPM oxygen concentrators in India (2026) — generic 5 LPM ranking without the chronic-use re-weighting
• Top 5 10 LPM oxygen concentrators in India (2026) — for COPD prescriptions above 5 LPM
• GOLD-stage COPD LTOT pathway in India — clinical pathway and indication detail
• Best oxygen concentrator for COPD patient at home — buyer checklist for COPD oxygen purchases
• Oxygen concentrator with nebulizer in India — if the COPD plan includes nebulized medication
• Hill-station oxygen therapy and altitude derating — if you’re at altitude
• Voltage stabiliser sizing for concentrators in India — the often-overlooked tier-2-city consideration
• Compare these models → — side-by-side spec comparison